Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population

NCT ID: NCT05311137

Last Updated: 2022-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2032-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy, the improvement of disease outcome and the economic value of the atrial fibrillation population in the northern Shanghai community. Improve the disease cognition of patients with atrial fibrillation, and promote the development of the concept of closed-loop treatment of atrial fibrillation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Closed-loop Group

Groups of Patients Adhering to Closed-Loop Therapy.

Radiofrequency ablation

Intervention Type PROCEDURE

Combined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.

No Closed-loop Group

Patients who have not undergone closed-loop treatment or patients who have not undergone standard surgery and medication.

No interventions assigned to this group

Exchange Group

Groups of patients with delayed compliance with closed-loop therapy for atrial fibrillation.

Radiofrequency ablation

Intervention Type PROCEDURE

Combined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radiofrequency ablation

Combined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cryoablation; left bundle branch pacing; left atrial appendage occlusion;

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* atrial fibrillation patients;Ability to act autonomously, understand and sign informed consent;

Exclusion Criteria

* none(All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up)
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai 10th People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ya-Wei Xu

Director, Director of Cardiovascular Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

WeiYa Xu, PhD

Role: STUDY_CHAIR

No. 301 Yanchang Middle Road, Jing'an District, Shanghai, China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

DongDong Zhao, PhD

Role: CONTACT

+86 18917684008

Jun Zhang, MD

Role: CONTACT

+86 15000420881

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jun Zhang, M.D.

Role: primary

+8615000420881

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CONTROL-AF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimal Ablation Strategies for Persistent AF With HF
NCT07153718 ACTIVE_NOT_RECRUITING NA
Shanghai Atrial Fibrillation Registry
NCT06802965 ENROLLING_BY_INVITATION
Complex Arrhythmia Registry
NCT07024927 NOT_YET_RECRUITING